In general, the patients with CAD had significantly higher serum LCN2 levels than non-CAD subjects (37.6 (25.2-56.3) vs. 31.1 (19.9-45.0) ng/mL, p < 0.01). Here, LCN2 is linked to coronary artery disorder.